Nka, A.D.; Bouba, Y.; Tsapi Lontsi, W.R.; Gouissi Anguechia, D.-H.; Teto, G.; Ka’e, A.c.; Semengue, E.N.J.; Ambe Chenwi, C.; Takou, D.; Forgwei, L.;
et al. Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries. Viruses 2025, 17, 69.
https://doi.org/10.3390/v17010069
AMA Style
Nka AD, Bouba Y, Tsapi Lontsi WR, Gouissi Anguechia D-H, Teto G, Ka’e Ac, Semengue ENJ, Ambe Chenwi C, Takou D, Forgwei L,
et al. Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries. Viruses. 2025; 17(1):69.
https://doi.org/10.3390/v17010069
Chicago/Turabian Style
Nka, Alex Durand, Yagai Bouba, Wilfried Rooker Tsapi Lontsi, Davy-Hyacinte Gouissi Anguechia, Georges Teto, Aude christelle Ka’e, Ezechiel Ngoufack Jagni Semengue, Collins Ambe Chenwi, Désiré Takou, Lum Forgwei,
and et al. 2025. "Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries" Viruses 17, no. 1: 69.
https://doi.org/10.3390/v17010069
APA Style
Nka, A. D., Bouba, Y., Tsapi Lontsi, W. R., Gouissi Anguechia, D.-H., Teto, G., Ka’e, A. c., Semengue, E. N. J., Ambe Chenwi, C., Takou, D., Forgwei, L., Tekoh, T. A.-K., Ngueko, A. M. K., Fokou, B. B., Efakika Gabisa, J., Tchouaket, M. C. T., TognaPabo, W. L., Ayuk Ngwese, D. T., Njiki Bikoi, J., Armenia, D.,
... Fokam, J.
(2025). Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries. Viruses, 17(1), 69.
https://doi.org/10.3390/v17010069
